Login
Toggle navigation
Videos
Categories
Trending
Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Invests globally and has offices in California, Israel, India, and China|Nicholas Brathwaite,Founder and Managing Partner,Celesta (fka WRVI)
00:10:00
Raymond Svider on Investment Discipline and Strategic Partnerships | Raymond Svider, Chairman, BC Partners.
00:10:00
Brazilian entrepreneur and VTEX co-founder Mariano Gomide brings his innovative vision and determination to pioneering the e-commerce market.
00:10:00
Unlocking Revenue and Digital Success: Shueisha's Cxense Strategy Revealed! | Christian Printzell Halvorsen, CEO, Cxense ASACXENSE:OSL
00:10:00
Ian Jamison on Exit Strategies and Changes in the PE Environment
00:10:00
Timmins Mayor George Pirie Launches Mining Projects Pipeline at Abitibi Virtual Event | Elisabeth Spatz DiVeto - President of New Brunswick Prospectors & Developers Association
00:10:00
Global Monetary Policy Conference Highlights: Uncommon Knowledge|John Taylor
00:10:00
Market Maverick: Investment Strategy and Unconventional Thinking|Brian Singerman,Investor, Founders Fund
00:10:00
Pegatron Corp. reports a significant increase from just 1% in 2021.|Mr. T.H. Tung is the Chairman & CSO of Pegatron Corporation
00:00:00
Datalab d.d. - 2015/16 National Champion | Stane Brlecic, CEO, Datalab ddDATG:LJU
00:10:00
Power of Disrupting Financial Systems|Kwame Anku,Chairman & CEO,Black Star Fund
00:10:00
Journey of Success: Dr. Garo Armen's Inspiring Life and Impact on Science, Entrepreneurship, and Philanthropy |Hartley Atkinson, CEO, AFT Pharmaceuticals Ltd .